Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis | NEJM 2019-12-19 https://t.co/Iky2Vr8jQM Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis 2019-09-03 https://t.co/5AllXaD7Eo
34,625 followers
1,085 followers
RT @FrontImmunol: New Research: Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis: Backgro…
1,255 followers
RT @FrontImmunol: New Research: Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis: Backgro…
7,381 followers
RT @FrontImmunol: New Research: Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis: Backgro…